DR. LUIS ALBERTO CAMPOS
Luis Alberto Campos has been working in biophysical studies related with proteins for the last two decades. In 2003, He obtained his PhD in biochemistry under the supervision of Prof. Javier Sancho at the University of Zaragoza, working on biophysical studies focused on protein folding and stability, and later, he continued his scientific studies with a postdoctoral stay at the University of Maryland in the laboratory directed by Prof. Victor Muñoz, using single molecule techniques to study protein folding. In 2008, he moved to the Centro de Investigaciones Biológicas, in Madrid, where he continued studying protein folding of barrierless proteins, being the recipient of a Marie Curie fellowship. Later on, he moved to the Centro Nacional de Biotecnología, in Madrid, where he obtained a Ramón y Cajal fellowship in 2014. There, he was the principal investigator of a National grant project focused on rational engineering of protein assemblies.
Nowadays, he has joined Dr. Alvaro Somoza´s laboratory in the IMDEA nanoscience institute, where he is going to participate in the improvement of detection and treatment methods using derivatized nanoparticles.
DR. MARIO MARTÍNEZ MINGO
Mario Martínez-Mingo obtained his BSc in Chemistry in 2015 from Universidad Autónoma de Madrid and his MSc in 2016 at the same university under the supervision of Dr. María Ribagorda and Prof. Carmen Carreño.
He then realized his PhD at Universidad Autónoma de Madrid under the supervision of Prof. Juan Carlos Carretero and Dr. Nuria Rodríguez focusing on the selective functionalization of C–H bonds through long-range metallacycle intermediates, stabilized by sulfur containing coordinating moieties. Currently, he joined Dr. Álvaro Somoza´s group as a post-doctoral researcher in IMDEA Nanoscience.
DR. HERNÁN ALARCÓN
Hernán Alarcón studied Biology at the Universidad Autónoma de Madrid where he collaborated on the analysis of different biomaterials for the treatment of bone diseases by using mesenchymal stem cells derived from the human bone marrow. After his graduate studies, he got his master’s degree in Biotechnology at the same university and worked as an internship researcher at the Molecular Biology Department. In 2019 he obtained his Ph.D. at the Molecular Biology Department of Universidad Autónoma de Madrid. His work was focused on the development of a lentiviral vector collection to express wild type and two mutant antagonist human prolactin hormones with the potential to describe the effect of human prolactin on various biological processes. Recently, he joined Dr. Begoña Sot’s group (IMDEA Nanoscience) as a Postdoctoral researcher to participate in the development of colorimetric sensors based on gold nanoparticles for the detection of SARS-CoV-2.
DR. NURIA LAFUENTE GÓMEZ
Nuria Lafuente-Gómez obtained her B.S. and M.S. in Pharmacy with honors at Universidad Complutense de Madrid (Spain, 2017). In 2018, she joined IMDEA Nanociencia as PhD candidate under the supervision of Prof. Álvaro Somoza and she currently holds a University Staff Training fellowship (FPU). During her doctoral training, she has also done two research stays in the University of Helsinki (Finland, 2020) and Harvard University (USA, 2021). Her PhD thesis was focused mainly on the development of magnetic nanoparticles for the diagnosis and treatment of cancer, including the evaluation of their biosafety and immunomodulatory properties.
DR. DEMIAN PARDO
Demian Pardo studied Biochemistry at Universidad Autónoma de Madrid, where he also obtained his master’s degree in biotechnology studying the “mechanisms implicated in the reprogramming of primordial germ cells and DNA damage caused by hypoxia” under the supervision of María Paz de Miguel Gonzalez . Then, he worked as laboratory technician at ¨Instituto de Química Orgánica General¨ at the oligosaccharides and glycosystems group in Spain till 2018.
In 2023 he finished his industrial PhD at IMDEA Nanociencia and Synthelia Organics under the supervision of Dr. Álvaro Somoza and Dr. Francisco Tato.
Fun facts: Cinnamon hater
DR. PAULA MILÁN ROIS
Paula Milán-Rois obtained her Biology degree and master in biomolecules and cell dynamics at Universidad Autónoma de Madrid. In 2017 she joined Prof. Álvaro Somoza’s group at IMDEA Nanociencia, where she carried out her PhD. During this period, she also did a research stay at Prof. Frank Slack at BIDMC/Harvard Medical School (USA, 2020).
She finished her PhD degree in 2023 that was focused in the therapy and diagnosis of different cancers. Her therapy proposal was based on balance the levels of ncRNAs which are implicated in tumor progression using gold or magnetic nanoparticles. Regarding diagnosis, she developed gold nanoparticle sensors to detect abnormal ncRNA levels or cancer mutations.